Whit Mayo
Stock Analyst at Leerink Partners
(2.55)
# 2,120
Out of 5,182 analysts
158
Total ratings
53%
Success rate
10.54%
Average return
Main Sectors:
Stocks Rated by Whit Mayo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ARDT Ardent Health | Maintains: Outperform | $16 → $15 | $9.27 | +61.81% | 3 | Mar 6, 2026 | |
| CLOV Clover Health Investments | Maintains: Market Perform | $3 → $2.5 | $2.03 | +23.15% | 5 | Mar 5, 2026 | |
| AHCO AdaptHealth | Maintains: Outperform | $13 → $12 | $12.32 | -2.60% | 12 | Feb 26, 2026 | |
| ACHC Acadia Healthcare Company | Maintains: Market Perform | $14 → $22 | $26.55 | -17.14% | 12 | Feb 26, 2026 | |
| EHAB Enhabit | Maintains: Market Perform | $9.5 → $14 | $13.98 | -1.29% | 3 | Feb 23, 2026 | |
| THC Tenet Healthcare | Maintains: Outperform | $255 → $264 | $192.99 | +36.79% | 15 | Feb 20, 2026 | |
| MD Pediatrix Medical Group | Maintains: Market Perform | $15 → $17 | $21.81 | -22.05% | 11 | Sep 5, 2025 | |
| ELV Elevance Health | Downgrades: Market Perform | $510 → $310 | $316.07 | -1.92% | 4 | Jul 18, 2025 | |
| AIRS AirSculpt Technologies | Maintains: Market Perform | $6.5 → $2.5 | $2.69 | -7.06% | 5 | Mar 31, 2025 | |
| HUM Humana | Downgrades: Market Perform | $400 → $250 | $198.23 | +26.12% | 12 | Oct 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $100 | $107.56 | -7.03% | 1 | Jul 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $15 | $46.03 | -67.41% | 1 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $625 → $560 | $313.00 | +78.91% | 11 | Jun 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $183.20 | - | 11 | May 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $98 → $97 | $141.62 | -31.51% | 1 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $309 → $335 | $275.12 | +21.77% | 5 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $238 → $286 | $497.42 | -42.50% | 17 | Dec 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $55 → $40 | $13.09 | +205.58% | 7 | Nov 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $46 → $39 | $23.01 | +69.49% | 7 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $825 → $750 | $21.63 | +3,367.41% | 5 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $235 → $175 | $65.46 | +167.34% | 1 | Apr 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $19 | $20.98 | -9.44% | 1 | Apr 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $5 → $4 | $3.06 | +30.72% | 6 | Jul 30, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Outperform | $183 → $203 | $264.18 | -23.16% | 2 | May 1, 2018 |
Ardent Health
Mar 6, 2026
Maintains: Outperform
Price Target: $16 → $15
Current: $9.27
Upside: +61.81%
Clover Health Investments
Mar 5, 2026
Maintains: Market Perform
Price Target: $3 → $2.5
Current: $2.03
Upside: +23.15%
AdaptHealth
Feb 26, 2026
Maintains: Outperform
Price Target: $13 → $12
Current: $12.32
Upside: -2.60%
Acadia Healthcare Company
Feb 26, 2026
Maintains: Market Perform
Price Target: $14 → $22
Current: $26.55
Upside: -17.14%
Enhabit
Feb 23, 2026
Maintains: Market Perform
Price Target: $9.5 → $14
Current: $13.98
Upside: -1.29%
Tenet Healthcare
Feb 20, 2026
Maintains: Outperform
Price Target: $255 → $264
Current: $192.99
Upside: +36.79%
Pediatrix Medical Group
Sep 5, 2025
Maintains: Market Perform
Price Target: $15 → $17
Current: $21.81
Upside: -22.05%
Elevance Health
Jul 18, 2025
Downgrades: Market Perform
Price Target: $510 → $310
Current: $316.07
Upside: -1.92%
AirSculpt Technologies
Mar 31, 2025
Maintains: Market Perform
Price Target: $6.5 → $2.5
Current: $2.69
Upside: -7.06%
Humana
Oct 2, 2024
Downgrades: Market Perform
Price Target: $400 → $250
Current: $198.23
Upside: +26.12%
Jul 10, 2024
Initiates: Outperform
Price Target: $100
Current: $107.56
Upside: -7.03%
Feb 20, 2024
Initiates: Outperform
Price Target: $15
Current: $46.03
Upside: -67.41%
Jun 14, 2023
Maintains: Outperform
Price Target: $625 → $560
Current: $313.00
Upside: +78.91%
May 26, 2023
Upgrades: Outperform
Price Target: n/a
Current: $183.20
Upside: -
Apr 3, 2023
Maintains: Overweight
Price Target: $98 → $97
Current: $141.62
Upside: -31.51%
Feb 8, 2023
Maintains: Market Perform
Price Target: $309 → $335
Current: $275.12
Upside: +21.77%
Dec 16, 2022
Maintains: Outperform
Price Target: $238 → $286
Current: $497.42
Upside: -42.50%
Nov 22, 2022
Maintains: Outperform
Price Target: $55 → $40
Current: $13.09
Upside: +205.58%
Nov 11, 2022
Maintains: Outperform
Price Target: $46 → $39
Current: $23.01
Upside: +69.49%
Nov 4, 2022
Maintains: Outperform
Price Target: $825 → $750
Current: $21.63
Upside: +3,367.41%
Apr 4, 2022
Maintains: Overweight
Price Target: $235 → $175
Current: $65.46
Upside: +167.34%
Apr 4, 2022
Initiates: Outperform
Price Target: $19
Current: $20.98
Upside: -9.44%
Jul 30, 2018
Maintains: Neutral
Price Target: $5 → $4
Current: $3.06
Upside: +30.72%
May 1, 2018
Assumes: Outperform
Price Target: $183 → $203
Current: $264.18
Upside: -23.16%